TTK Healthcare Limited (TTKHLTCARE.NS)
INR 1456.8
(-2.39%)
INR 1456.8
(-2.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -7.52 Billion INR | -4276.55% |
| 2022 | 180.08 Million INR | 145.07% |
| 2021 | 73.48 Million INR | -23.37% |
| 2020 | 95.89 Million INR | -57.02% |
| 2019 | 223.08 Million INR | 28.3% |
| 2018 | 173.87 Million INR | -46.6% |
| 2017 | 325.64 Million INR | 155.05% |
| 2016 | -591.57 Million INR | -52.94% |
| 2015 | -386.8 Million INR | -8.69% |
| 2014 | -355.86 Million INR | 32.29% |
| 2013 | -525.57 Million INR | 14.35% |
| 2012 | -613.62 Million INR | -39.83% |
| 2011 | -438.83 Million INR | 9.33% |
| 2010 | -483.99 Million INR | -38.05% |
| 2009 | -350.58 Million INR | 0.08% |
| 2008 | -350.86 Million INR | 4.18% |
| 2007 | -366.17 Million INR | -198.51% |
| 2006 | -122.67 Million INR | -1029.95% |
| 2005 | -10.85 Million INR | -114.94% |
| 2004 | 72.67 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 8.45 Billion INR | 212.38% |
| 2024 Q2 | 206.26 Million INR | -97.44% |
| 2023 Q3 | 8.44 Billion INR | 4801.25% |
| 2023 Q2 | 172.39 Million INR | -97.96% |
| 2023 Q1 | 8.46 Billion INR | 4601.52% |
| 2023 FY | -7.52 Billion INR | -4276.55% |
| 2023 Q4 | -7.52 Billion INR | -189.01% |
| 2022 Q3 | 9.51 Billion INR | 830.65% |
| 2022 Q2 | -1.3 Billion INR | -147.73% |
| 2022 Q1 | 2.72 Billion INR | 3615.02% |
| 2022 FY | 180.08 Million INR | 145.07% |
| 2022 Q4 | 180.08 Million INR | -98.11% |
| 2021 FY | 73.48 Million INR | -23.37% |
| 2021 Q4 | 73.48 Million INR | -97.04% |
| 2021 Q1 | 2.26 Billion INR | 2267.26% |
| 2021 Q2 | -58.91 Million INR | -102.6% |
| 2021 Q3 | 2.47 Billion INR | 4308.3% |
| 2020 Q2 | -15.49 Million INR | -101.12% |
| 2020 Q1 | 1.38 Billion INR | 519.33% |
| 2020 FY | 95.89 Million INR | -57.02% |
| 2020 Q3 | 2.09 Billion INR | 13591.08% |
| 2020 Q4 | 95.89 Million INR | -95.41% |
| 2019 Q4 | 223.08 Million INR | -83.56% |
| 2019 FY | 223.08 Million INR | 28.3% |
| 2019 Q3 | 1.35 Billion INR | 821.82% |
| 2019 Q2 | 147.18 Million INR | -88.1% |
| 2019 Q1 | 1.23 Billion INR | 611.35% |
| 2018 Q2 | 157.43 Million INR | -84.31% |
| 2018 FY | 173.87 Million INR | -46.6% |
| 2018 Q1 | 1 Billion INR | 208.14% |
| 2018 Q4 | 173.87 Million INR | -86.17% |
| 2018 Q3 | 1.25 Billion INR | 698.36% |
| 2017 Q4 | 325.64 Million INR | -68.7% |
| 2017 Q3 | 1.04 Billion INR | 255.43% |
| 2017 Q2 | -669.29 Million INR | -181.45% |
| 2017 Q1 | 821.73 Million INR | 238.91% |
| 2017 FY | 325.64 Million INR | 155.05% |
| 2016 Q1 | 872.96 Million INR | 325.68% |
| 2016 FY | -591.57 Million INR | -52.94% |
| 2016 Q4 | -591.57 Million INR | -178.99% |
| 2016 Q3 | 748.92 Million INR | 100.0% |
| 2016 Q2 | -41235.74 Billion INR | -4723737.49% |
| 2015 FY | -386.8 Million INR | -8.69% |
| 2015 Q1 | 774.33 Million INR | 317.59% |
| 2015 Q4 | -386.8 Million INR | -146.32% |
| 2015 Q3 | 835.12 Million INR | 285.23% |
| 2015 Q2 | -450.86 Million INR | -158.23% |
| 2014 Q2 | -482.64 Million INR | -157.33% |
| 2014 Q3 | 897.76 Million INR | 286.01% |
| 2014 Q1 | 841.92 Million INR | 260.19% |
| 2014 FY | -355.86 Million INR | 32.29% |
| 2014 Q4 | -355.86 Million INR | -139.64% |
| 2013 Q2 | -518.09 Million INR | -161.29% |
| 2013 FY | -525.57 Million INR | 14.35% |
| 2013 Q1 | 845.31 Million INR | 237.76% |
| 2013 Q4 | -525.57 Million INR | -169.66% |
| 2013 Q3 | 754.47 Million INR | 245.63% |
| 2012 FY | -613.62 Million INR | -39.83% |
| 2012 Q4 | -613.62 Million INR | 0.0% |
| 2011 FY | -438.83 Million INR | 9.33% |
| 2011 Q4 | -438.83 Million INR | 0.0% |
| 2010 FY | -483.99 Million INR | -38.05% |
| 2009 FY | -350.58 Million INR | 0.08% |
| 2008 FY | -350.86 Million INR | 4.18% |
| 2007 FY | -366.17 Million INR | -198.51% |
| 2006 FY | -122.67 Million INR | -1029.95% |
| 2005 FY | -10.85 Million INR | -114.94% |
| 2004 FY | 72.67 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott India Limited | -20.51 Billion INR | 63.333% |
| Cipla Limited | -3.15 Billion INR | -138.348% |
| Gland Pharma Limited | -14.67 Billion INR | 48.739% |
| GlaxoSmithKline Pharmaceuticals Limited | -674.11 Million INR | -1015.737% |
| Kopran Limited | 850.3 Million INR | 984.544% |
| Marksans Pharma Limited | -4.29 Billion INR | -75.111% |
| NGL Fine-Chem Limited | 307.22 Million INR | 2548.148% |
| Pfizer Limited | -19.52 Billion INR | 61.472% |
| Sanofi India Limited | -3.87 Billion INR | -94.098% |
| SMS Pharmaceuticals Limited | 2.44 Billion INR | 407.534% |